Alexis Black
Family · Luling, LANPI 1649943937
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,017, more than ten times the $221 reported in 2021. Among family clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $65.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$939
- Teva Pharmaceuticals USA, Inc.$607
- Sanofi$482
- E.r. Squibb & Sons, L.L.C.$429
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$396
- Johnson & Johnson$394
- plus $5K from 37 others
What the payments were for
- Speaking & faculty fees$340%
- Food & beverage$8,016100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$616
- Austedo XR$607
- UPTRAVI$384
- OPSUMIT$384
- FABRAZYME$364
- VRAYLAR$249
- DUPIXENT$237
- VALTOCO$233
- DEXCOM G7 GSS (161)$163
- DEXCOM STELO GLUCOSE BIOSENSOR$163
- FREESTYLE LIBRE 3$163
- REZDIFFRA$147
- Kerendia$140
- FLOWTRIEVER CATHETER, S$138
- CT THROMBECTOMY SYSTEM KIT$138
- VTAMA$138
- Epclusa$132
- TEZSPIRE$129
- VOQUEZNA$125
- JARDIANCE$125
How this compares
$8,050 in reported general payments places this provider in the 95th percentile of 3,610 family providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 169 | $169,131 |
| EntrestoSacubitril/Valsartan | 125 | $111,492 |
| XareltoRivaroxaban | 33 | $39,260 |
| JardianceEmpagliflozin | 14 | $13,262 |
| BrilintaTicagrelor | 15 | $8,438 |
| Repatha SureclickEvolocumab | 15 | $7,946 |
| Atorvastatin Calcium | 243 | $1,763 |
| Metoprolol Succinate | 162 | $1,448 |
| Cilostazol | 62 | $1,291 |
| Losartan Potassium | 101 | $819 |
| Hydralazine Hcl | 34 | $753 |
| Amlodipine Besylate | 166 | $713 |
| Furosemide | 199 | $675 |
| Rosuvastatin Calcium | 71 | $670 |
| ClopidogrelClopidogrel Bisulfate | 117 | $649 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $69 | $169,131169 claims |
| NovartisEntresto | $193 | $111,492125 claims |
| Johnson & JohnsonXarelto | $394 | $39,26033 claims |
| Boehringer IngelheimJardiance | $125 | $13,26214 claims |
| AstraZenecaBrilinta | $368 | $8,43815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,610 family providers in Louisiana.
Other family in Luling
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.